Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1987-11-19
pubmed:abstractText
1. Actions of the neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2) and its derivative YGG-FMRFamide (Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2) on Ca2+ current were examined in identified, voltage-clamped neurones in the abdominal ganglion of Aplysia californica. 2. 'Puffed' application of either peptide at concentrations of 1-50 microM was followed by a transient partial suppression of pharmacologically isolated inward Ca2+ current elicited by a depolarizing step. At 20 degrees C, suppression was maximal 10-25 s following the brief puff of peptide, and lasted up to 90 s. Bath application of peptide had a steady suppressing effect, showing little if any desensitization. 3. Alternative sources of inward current suppression were ruled out, indicating that application of FMRFamide or YGG-FMRFamide produces a true decrease in Ca2+ current, rather than enhancement of possible contaminating outward (K+, H+ or Cl-) currents. 4. FMRFamide and YGG-FMRFamide were equally effective in suppressing Ca2+ current (apparent dissociation constant, KD* approximately 10 microM). However, only 30-50% of the total Ca2+ current elicited by voltage steps to above +10 mV appeared to be susceptible to suppression by even saturating concentrations of peptide. This, as well as a reduced effect of the peptides on Ca2+ current which was observed at potentials below +10 mV, may perhaps result from the presence of more than one class of Ca2+ channels, only one of which is sensitive to FMRFamide. 5. FMRFamide eliminated a constant fraction of Ca2+ current at all potentials above +10 mV, and had no direct effect on activation or inactivation of the remaining current. This behaviour is consistent with reduction in the number of functional Ca2+ channels by the peptide. 6. Suppression of Ca2+ current produced a concomitant depression of Ca2+-dependent K+ current, which was shown previously to be insensitive to FMRFamide when activated by direct ionophoretic injection of Ca2+ into the cell. 7. The effect of FMRFamide on Ca2+ current was normal following interference with or activation of known second-messenger systems, those involving adenosine 3',5'-cyclic monophosphate (cyclic AMP), cyclic GMP, Ca2+, inositol trisphosphate and protein kinase C. 8. Suppression of Ca2+ current by FMRFamide appeared to be mediated by the same receptor as enhancement by the peptide of K+ current resembling IK(S) (K+ current suppressed by serotonin), an effect seen in most of the same cells. Both effects of FMRFamide were mimicked by injection of guanosine 5'-O-(3-thiotriphosphate) (GTP-gamma-S) into the cell, suggesting that the peptide may exert its effects by activating a guanosine 5'-triphosphate (GTP)-binding protein
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-1177091, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-193029, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2409514, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2411887, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2413368, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2414442, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2417236, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2419525, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2419757, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2429251, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2432242, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2442363, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2578617, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2579349, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2582078, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-28527, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-2984670, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-352237, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-3838698, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-4084949, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-4838803, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-5279794, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-5564761, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-5575340, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6086903, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6095092, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6095365, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6096869, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6114129, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6118434, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6147396, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6232463, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6255107, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6256770, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6261668, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6265594, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6266592, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6281880, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6289122, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6308462, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6320002, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6321035, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6323696, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6438083, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-6683482, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-7006829, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-7070195, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-7230018, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-7310398, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-839456, http://linkedlifedata.com/resource/pubmed/commentcorrection/2443695-877582
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP, http://linkedlifedata.com/resource/pubmed/chemical/Enkephalin, Methionine, http://linkedlifedata.com/resource/pubmed/chemical/FMRFamide, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine 5'-O-(3-Thiotriphosphate), http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Ion Channels, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuropeptides, http://linkedlifedata.com/resource/pubmed/chemical/Potassium, http://linkedlifedata.com/resource/pubmed/chemical/Thionucleotides, http://linkedlifedata.com/resource/pubmed/chemical/enkephalin-Met, Arg(6)-PheNH2(7)-
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:volume
388
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
565-95
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
More...